Evaluation of MCM5 in Postmenopausal Bleeding Patients
Condition(s):Endometrial CancerLast Updated:February 1, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Endometrial CancerLast Updated:February 1, 2023Recruiting
Condition(s):History of Covid-19, SeroprevalenceLast Updated:June 24, 2020Unknown status
Condition(s):Hepatic Vein Thromboses; Hepatic Venous Outflow Obstruction; Portal Vein Thrombosis; Portal Hypertension, Noncirrhotic; Portal Vein Occlusion; Portal Vein Embolism; JAK2 Mutation; CALR Gene Mutation; Prothrombin G20210A; Anticoagulants and Bleeding DisordersLast Updated:February 13, 2024Recruiting
Condition(s):COVID-19 Respiratory InfectionLast Updated:May 17, 2023Completed
Condition(s):Vaccine ReactionLast Updated:July 6, 2023Completed
Condition(s):SARS-CoV-2Last Updated:December 17, 2020Completed
Condition(s):Salivary ImmunityLast Updated:February 8, 2024Completed
Condition(s):Hepatocellular CarcinomaLast Updated:July 29, 2021Completed
Condition(s):Rheumatoid ArthritisLast Updated:October 6, 2022Not yet recruiting
Condition(s):Parkinson Disease and HydrotherapyLast Updated:February 12, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.